JO

Journal of Crohn s and Colitis

Journal of Crohn’s and Colitis is a gastroenterology journal published by Oxford University Press for the European Crohn's and Colitis Organisation (ECCO). It publishes research on Crohn’s disease, ulcerative colitis, inflammatory bowel disease, guidelines, consensus papers, reviews, and related content. The journal has a 2024 Impact Factor of 8.7 and a 2024 CiteScore of 15.6. Online ISSN: 1876-4479.

Looking to publish in Journal of Crohn s and Colitis? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Impact Factor 8.7
Quartile Q1
Open Access Type Hybrid
ISSN 1873-9946
eISSN 1876-4479
Invitation Only No
Cost Range Subscription journal with open access publishing options available, including publication through institutional Read and Publish agreements.

Submission Instructions

Journal of Crohn s and Colitis accepts the following article types. Click on an article type to view submission instructions.

Original Article

Cover Letter A covering letter signed by the corresponding author on behalf of all authors must be submitted. The cover letter must state author approval and substantial contributions, confirm the manuscript with related data, figures, and tables is unpublished and not under consideration elsewhere, disclose financial conflicts of interest, explain any joint or equal first authorship request, disclose any use of artificial intelligence tools, and provide the names and contact details of three potential reviewers.
Abstract An abstract is required. The abstract must not exceed 250 words. The abstract must be structured. The abstract must use the headings Background and Aims, Methods, Results, and Conclusions.
Manuscript Original Articles must not exceed 7,500 words plus references. Original Articles must be organized as Title Page, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgements, References, Figure Legends, Tables, and Figures. The manuscript must include an Authors' contributions section, a separate Funding section, a separate Conflict of Interest Statement, up to three keywords after the abstract, alt text under each figure legend, and disclosure of any artificial intelligence tool use in the Methods or Acknowledgements section.
References References must be cited by superscript Arabic numerals in citation order and the reference list must present abbreviated journal titles, all authors' names, article titles, and inclusive page numbers.
Figures & Tables The number of figures and tables must be in balance with the length of the manuscript. For submission, figures may be uploaded either embedded in the manuscript file or separately, and the graphical abstract must be submitted as a separate file. Alt text must be included under each figure legend in the manuscript, and the graphical abstract must be clearly named and in landscape format.
Reformat to Journal of Crohn s and Colitis using Livewrite Premium

Review Article

Cover Letter A covering letter signed by the corresponding author on behalf of all authors must be submitted with the manuscript. The covering letter must state that all authors made substantial contributions, critically drafted or revised the article, gave final approval of the submitted version, that the manuscript including related data, figures, and tables has not been previously published or submitted elsewhere, disclose financial conflicts of interest, and disclose any use of artificial intelligence tools.
Abstract An abstract is required for Review Articles. The abstract must not exceed 250 words. The abstract must be structured. The abstract must use the headings Background and Aims, Methods, Results, and Conclusions.
Manuscript Review Articles must not exceed 7,500 words plus references. Review Articles must be organized in the following sections: Title Page, Abstract, Main text, Acknowledgement, References, Figure Legends, Tables, Figures. The manuscript must include a separate 'Authors' contributions' heading listing each author's contribution, a separate Funding section before Acknowledgements, a separate Conflict of Interest Statement paragraph, disclosure of any AI tool use in the Methods or Acknowledgements section, and a maximum of three keywords immediately after the abstract.
References References must be cited by Arabic numerals in superscript and numbered in the order cited, with all authors' names, article titles, inclusive pages, and Index Medicus journal abbreviations used in the reference list.
Figures & Tables Review Articles must include at least 2 figures and 2 tables. For submission, figures may be uploaded either embedded in the manuscript file or separately, and the graphical abstract must be submitted as a separate file. Alt text must be included under each figure legend in the main manuscript file, and the graphical abstract must be clearly named and provided in landscape format.
Reformat to Journal of Crohn s and Colitis using Livewrite Premium

Viewpoint

Cover Letter A covering letter signed by the corresponding author on behalf of all authors must be submitted with the manuscript. Cover letter must state that all authors meet the specified contribution and final approval criteria, that the manuscript including related data, figures, and tables has not been previously published or submitted elsewhere, must disclose financial conflicts of interest and any AI use, and must explain any request for joint or equal first authorship.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract must be structured. Abstract must use the headings Background and Aims, Methods, Results, and Conclusions.
Manuscript Viewpoints must not exceed 3,000 words. A separate heading titled Authors' contributions must be included in the manuscript. Manuscript must include an Authors' contributions section, separate Funding and Conflict of Interest Statement sections, AI use disclosure in the Methods or Acknowledgements section, and a maximum of three keywords immediately after the abstract.
References References must be cited by Arabic numerals in superscript in citation order, listed in the same order, use Index Medicus journal title abbreviations, and include all authors' names, article titles, and inclusive pages.
Figures & Tables For submission, figures may be uploaded either embedded in the manuscript file or separately as low-resolution images. Alt text descriptions must be provided in the main manuscript file directly under each relevant figure legend and preceded by 'Alt text:'.
Reformat to Journal of Crohn s and Colitis using Livewrite Premium

Short Report

Cover Letter A covering letter signed by the corresponding author on behalf of all authors must be submitted with the manuscript. The cover letter must state that all authors made substantial contributions, revised or drafted the article, approved the submitted version, that the manuscript has not been previously published or submitted elsewhere, and disclose any use of artificial intelligence tools.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract must be structured. Abstract must use the headings Background and Aims, Methods, Results, and Conclusions.
Manuscript Manuscript must not exceed 1,500 words. Short Report must be organized as Title Page, Abstract, Introduction, Case Report, Discussion, Acknowledgements, References, Figure Legends, Tables, and Figures. The manuscript must include separate sections for Authors' contributions, Funding, and Conflict of Interest Statement, include 1–3 keywords after the abstract, and disclose any use of artificial intelligence tools in the Methods or Acknowledgements section.
References References must be cited by superscript Arabic numerals in citation order, listed in the same order, use Index Medicus journal abbreviations, include all authors' names, article titles, and inclusive page numbers, and exclude unpublished data and personal communications from the reference list.
Figures & Tables For submission, figures may be uploaded either embedded in the manuscript file or separately. Alt text must be provided in the main manuscript file directly under each relevant figure legend.
Reformat to Journal of Crohn s and Colitis using Livewrite Premium

Letter To The Editor

Cover Letter A covering letter signed by the corresponding author on behalf of all authors must be submitted with the manuscript. The covering letter must state that all authors made substantial contributions, critically drafted or revised the article, gave final approval, that the manuscript has not been previously published or submitted elsewhere, and must disclose any use of artificial intelligence tools.
Abstract Abstract requirements are not specified.
Manuscript Letters To The Editor must not exceed 450 words excluding references. Letters To The Editor must have no more than 3 authors.
References Letters To The Editor may include no more than 5 references. References must be cited in the text by Arabic numerals in superscript and numbered in the order in which they are cited.
Figures & Tables Letters To The Editor may include one figure or one small table. Figures may be uploaded either embedded in the manuscript file or separately for submission.
Reformat to Journal of Crohn s and Colitis using Livewrite Premium

Editorial

Cover Letter A covering letter signed by the corresponding author on behalf of all authors must be submitted with the manuscript. Cover letter must state that all authors made substantial contributions, approved the submitted version, that the manuscript including related data, figures and tables has not been previously published or under consideration elsewhere, disclose financial conflicts of interest, and disclose any use of artificial intelligence tools.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract must be structured. Abstract must use the headings Background and Aims, Methods, Results, and Conclusions.
Manuscript Editorial must not exceed 800 words. Manuscript must include an 'Authors' contributions' section, a separate 'Funding' section before 'Acknowledgements', a separate conflict of interest statement, and a disclosure of any artificial intelligence tool use in the Methods or Acknowledgements section.
References Editorial may include no more than 10 references. References must be cited in the text by superscript Arabic numerals in citation order, listed at the end of the text in the same order, use Index Medicus journal abbreviations, include all authors' names, article titles, and inclusive pages, and exclude unpublished data and personal communications from the reference list.
Figures & Tables Figures for submission may be uploaded either embedded in the manuscript file or separately as low-resolution images. Alt text descriptions must be provided in the main manuscript file directly under each relevant figure legend.
Reformat to Journal of Crohn s and Colitis using Livewrite Premium

Recent Publications

Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease

Marie Truyens, Xenia Tolstoy, Giulio Calabrese, Anneline Cremer, Konrad Lewandowski, Konstantinos Argyriou, Ioannis Drygiannakis, Eathar Shakweh, Ploutarchos Pastras, Haluk Tarik Kani, María José García, Hannah Gordon, Davide Giuseppe Ribaldone, Konstantinos Karmiris, Carla Felice, Irene Moraleja Yudego, Andreas Blesl, Alessia Todeschini, Paola Balestrieri, Rafal Filip, Thibault Taelman, Nora Vladimirova, Georgios Michalopoulos, Mohamed Attauabi, Lieven Pouillon, Nurulamin Noor, Tommaso Innocenti, Sophie Vieujean, Tarkan Karakan, Manuel Barreiro-de Acosta, Giammarco Mocci, Maria Manuela Estevinho, Edoardo Vincenzo Savarino, Aranzazu Jauregui-Amezaga, Tom Holvoet, Christina Kapizioni, Gizem Dagci, Spyridon Vrakas, Charlotte R H Hedin, Olga Maria Nardone, Grażyna Rydzewska, Ioannis Koutroubakis, Ioannis Psaroudakis, Gabriele Dragoni, Jeroen Geldof, Gaëlle Varkas, Jo Lambert, Triana Lobatón

10.1093/ecco-jcc/jjag129
View Publication

Experience-based reappraisal of the IBD-DCA histopathological scoring system

David Egong, Glen Doherty, Kieran Sheahan

10.1093/ecco-jcc/jjag131
View Publication

2′-Fucosyllactose modulates gut microbiota and systemic metabolism in mild-to-moderate ulcerative colitis: a randomized crossover trial

James M Kennedy, Aminda N De Silva, Patricia Sanz Morales, Carlos G Poveda Turrado, Gemma E Walton, Glenn R Gibson

10.1093/ecco-jcc/jjag120
View Publication

BRD4 contributes to the cytokine-induced acquisition of an IL-13RA2-positive inflammatory fibroblast phenotype

Rachele Frascatani, Mattia Alberto Serra, Andrea Iannucci, Marco Colella, Claudia Maresca, Irene Marafini, Elisabetta Lolli, Giorgia Sena, Andrea Divizia, Andrea Martina Guida, Giuseppe Sigismondo Sica, Giovanni Monteleone

10.1093/ecco-jcc/jjag128
View Publication

Automated AI-based Mayo Endoscopic Scoring for ulcerative colitis across adult and pediatric cohorts from diverse populations

Kamal Hammouda, Rishi Dakarapu, Chathruckan Rajendra, Hyojeong Lee, Sahar Almahfouz Nasser, Sharmistha Rudra, Vasantha Kolachala, Caitlin Diefendorf, Irina Geiculescu, Sushma Maddipatla, Anant Madabhushi, Subra Kugathasan

10.1093/ecco-jcc/jjag122
View Publication

Frequently asked questions

How long does it take to publish?

2025 median days from acceptance to publication: 21 days.

Reformat to Journal of Crohn s and Colitis using Livewrite Premium

Is a cover letter required?

A covering letter is expected when explaining the case for joint or equal first authorship.

Reformat to Journal of Crohn s and Colitis using Livewrite Premium

What are the publication costs?

Subscription journal with open access publishing options available, including publication through institutional Read and Publish agreements.

Reformat to Journal of Crohn s and Colitis using Livewrite Premium

Research Topics

Inflammatory Bowel Disease Microscopic Colitis Eosinophilic Esophagitis Biosimilars and Bioanalytical Methods Diverticular Disease and Complications Autoimmune and Inflammatory Disorders Immunodeficiency and Autoimmune Disorders Helicobacter pylori-related gastroenterology studies Gut microbiota and health Diagnosis and treatment of tuberculosis Pregnancy and Medication Impact Liver Diseases and Immunity Celiac Disease Research and Management Pharmaceutical studies and practices Adolescent and Pediatric Healthcare Colorectal Cancer Screening and Detection Anorectal Disease Treatments and Outcomes Gastric Cancer Management and Outcomes Health Systems, Economic Evaluations, Quality of Life Gastrointestinal motility and disorders Mycobacterium research and diagnosis Colorectal Cancer Surgical Treatments Clostridium difficile and Clostridium perfringens research Systemic Lupus Erythematosus Research Chronic Lymphocytic Leukemia Research